This article provides an overview of how varenicline and electronic cigarettes have been used in the United States to help smokers quit over the past decade. It discusses their effectiveness and role in tobacco control strategies.
By comparing these two cessation tools, the article aims to inform policymakers, healthcare providers, and the public about their potential benefits and limitations in reducing smoking prevalence.